Evidence base

Evidence base is the body of published research that exists on a given question, considered as a whole — not any single study, but the entire record: how many studies have been conducted, what designs they used, how consistent their results are, and where the record stops.

On these pages the term carries two simultaneous meanings. It describes the quantity of available work — a well-studied compound may have hundreds of published studies; a recently emerging psychoactive may have none. And it describes the quality of that work — whether it rests on controlled trials, on case reports, on animal models only, or on some combination. Both dimensions matter when reading a claim.

What this design can establish

A well-characterised evidence base establishes the state of knowledge at a point in time: whether a question has been seriously investigated, whether findings replicate across independent groups, which study designs have been brought to bear, and how far agreement extends.

It can also surface the shape of what is missing. A systematic review that maps an evidence base will note which populations were not included, which routes of administration went untested, and which outcomes no one measured. That map of gaps is itself a real finding — not a deficiency of the review, but a statement about the record.

What it cannot

An evidence base cannot tell you whether something is safe or effective — only how thoroughly those questions have been examined. A thin evidence base is not evidence of safety; it is evidence of having been less studied.

The inference a reader is most likely to draw incorrectly is that few adverse events in the literature implies low risk. But a case-report corpus with no recorded serious harms is exactly what you would expect whether a substance is genuinely benign or whether it is harmful and simply unstudied. An absence of published findings is not a finding of absence.

For much of the corpus on this site — particularly novel psychoactives, research chemicals, and traditional plant preparations that have not passed through clinical development — the honest characterisation is that the evidence base is thin or absent. That statement describes a gap in the scientific record, not a verdict on the substance.